Kevin Mcnamara Sells 2,000 Shares of Chemed (NYSE:CHE) Stock

Chemed Corporation (NYSE:CHE) CEO Kevin Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $539.51, for a total value of $1,079,020.00. Following the completion of the transaction, the chief executive officer directly owned 70,418 shares of the company’s stock, valued at $37,991,215.18. This trade represents a 2.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Chemed Trading Up 1.1%

Shares of CHE stock opened at $545.55 on Thursday. The firm has a market capitalization of $7.13 billion, a PE ratio of 27.40, a price-to-earnings-growth ratio of 2.04 and a beta of 0.51. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $551.68. The stock has a fifty day moving average of $473.28 and a two-hundred day moving average of $438.37.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, topping the consensus estimate of $5.60 by $0.46. The business had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The company’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $4.27 earnings per share. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, research analysts expect that Chemed Corporation will post 23.18 EPS for the current year.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were given a $0.60 dividend. The ex-dividend date was Thursday, May 28th. This represents a $2.40 annualized dividend and a yield of 0.4%. Chemed’s payout ratio is 12.05%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Commonwealth Equity Services LLC increased its position in shares of Chemed by 3.1% during the fourth quarter. Commonwealth Equity Services LLC now owns 734 shares of the company’s stock worth $314,000 after acquiring an additional 22 shares in the last quarter. Cim LLC increased its stake in Chemed by 1.1% in the 3rd quarter. Cim LLC now owns 2,139 shares of the company’s stock valued at $958,000 after buying an additional 24 shares during the last quarter. Eukles Asset Management grew its holdings in shares of Chemed by 0.4% in the 4th quarter. Eukles Asset Management now owns 6,056 shares of the company’s stock valued at $2,591,000 after acquiring an additional 25 shares in the last quarter. MassMutual Private Wealth & Trust FSB grew its holdings in shares of Chemed by 65.3% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company’s stock valued at $38,000 after acquiring an additional 32 shares in the last quarter. Finally, EverSource Wealth Advisors LLC increased its position in shares of Chemed by 9.4% in the first quarter. EverSource Wealth Advisors LLC now owns 406 shares of the company’s stock valued at $153,000 after acquiring an additional 35 shares during the last quarter. 95.85% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on CHE. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Wall Street Zen raised shares of Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. Bank of America reissued a “neutral” rating on shares of Chemed in a research note on Wednesday, July 29th. Oppenheimer increased their price target on shares of Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a research note on Friday, July 31st. Finally, Royal Bank Of Canada raised their price objective on Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research note on Thursday, July 30th. One research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $530.75.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.